Microbiome Therapeutics prepares to launch first microbiome modulator after completing Series B financing

261828b1-e8b6-4c71-a5dc-0270aa80590barticleimage.jpg

08 Nov 2017 --- MicroBiome Therapeutics, LLC (MBT), a company that applies the science of the gastrointestinal (GI) microbiome to promote health and wellness, has announced the completion of a Series B financing that raised approximately US$1 million. MBT intends to use the proceeds to launch its clinically-tested microbiome modulator product in 2018.

The dietary supplement is specifically designed to balance and optimize the GI tract and promote healthy metabolism by nourishing and nurturing the growth of healthful gut bacteria, MBT notes. New and existing investors include Lagniappe Angels, NO/LA Angel Network, Zehnder Communications and other private investors.

“We appreciate the support of our investors, which will enable the planned launch of our lead microbiome modulator next year,” says Dale Pfost, Acting CEO of MBT. “This product is a scientific formulation of natural ingredients designed to support a balanced GI microbiome and promote metabolic health in an easy-to-use, flavorful drink mix.”

“Our two clinical trials, conducted at the Pennington Biomedical Research Center and reported in peer-reviewed publications, demonstrated its benefits in helping to manage hunger, maintain healthy blood sugar levels and promote regularity,” Pfost adds.

The product is described as an all-natural blend of prebiotics, including fermentable fiber and polyphenol antioxidants in a patent-pending blend intended to help nurture and nourish beneficial microorganisms in the lower gut.

MBT reports that the launch of its microbiome modulator will be supported by a two-year e-commerce and social media campaign conducted in partnership with New Orleans-based advertising agency Zehnder Communications. MBT is also assembling a nationwide network of registered dietitians and certified diabetic educators to support the launch.

“With MicroBiome Therapeutics, we saw a unique opportunity to apply our product launch expertise in support of an exciting, first-in-class product from a leading science-based company,” says Jeremy Hunnewell, CFO and Business Strategist for Zehnder Communications. “We believe our expertise, along with our integrative and analytical approaches, will enable MBT to inform and educate consumers about this exciting new type of health-promoting dietary supplement.”

“Our investment reinforces our commitment to making a difference by playing a part in the microbiome revolution,” states Hunnewell, who will be joining the board of directors of MBT.

Related Articles

Nutrition & Health News

Kellogg’s launches organic and vegan plant-based “no added sugar” cereals

24 Nov 2017 --- Kellogg’s is to enter the organic and vegan foods market with a new range of, plant-based cereals under the W.K.Kellogg brand. The five-strong range – including two “No Added Sugar” granolas – will be completely unique to the cereal market offering differentiated natural flavors, according to Kellogg’s.

Business News

Fibers and proteins among Naturex’s expansion and diversification strategy

24 Nov 2017 --- Over the past months, Naturex has moved to boost its presence in the natural nutrition market with the acquisition of Swedish Oat Fiber, a specialized manufacturer of oat dietary fibers, oils and proteins, as well as the signing of a global distribution agreement via its Open Innovation program (Ingenium) with a Colorado-based start-up, MycoTechnology, for their PureTaste, shiitake mushroom plant protein created by patent-pending fungi fermentation technology.

Nutrition & Health News

Benefits of coffee consumption noted in BMJ amid coffee’s strong showing in marketplace

23 Nov 2017 --- Drinking coffee is “more likely to benefit health than to harm it” for a range of health outcomes, according to researchers in The BMJ today. The researchers’ findings only enhance a good period for coffee products, as Innova Market Insights’ top trends for 2018 note that coffee is clearly trending, especially among Millennial and Generation Z consumers.

Nutrition & Health News

Mass media linked to childhood obesity by European task force study

23 Nov 2017 --- A task force from the European Academy of Pediatrics and the European Childhood Obesity Group has found evidence of a strong link between obesity levels across European countries and childhood media exposure. The findings indicate that parents and society need a better understanding of the influence of social media on dietary habits. In addition, health policies in Europe must take account of the range of mass media influences that promote the development of childhood obesity, according to the experts.

Nutrition & Health News

Vitamin K2 could be novel therapeutic target for common cardiovascular condition

23 Nov 2017 --- The European Heart Journal has published a review paper that highlights the potential of vitamin K2 supplementation for calcific aortic valve stenosis (CAVS), a common cardiovascular condition in the aging population where no medical therapy currently exists.

More Articles
URL : http://www.nutritioninsight.com:80/news/microbiome-therapeutics-prepares-to-launch-first-microbiome-modulator-after-completing-series-b-financing.html